Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00502073 · ClinicalTrials.gov registry record · Phase 3

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

A Phase 3 study of Dry Eye Syndromes, sponsored by Sirion Therapeutics.

Completed
Registry status
Phase 3
Development phase
1
Study location

NCT00502073: Completed Phase 3 study of Dry Eye Syndromes, sponsored by Sirion Therapeutics.

NCT00502073 is a Phase 3 study of Dry Eye Syndromes that has completed, run by Sirion Therapeutics. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00502073, a Phase 3 study of Dry Eye Syndromes, has completed, sponsored by Sirion Therapeutics.

COMPLETED
Registry status
Phase 3
Development phase
1
Study location

Study Summary

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Conditions Studied

Dry Eye Syndromes

Interventions

  • DRUG cyclosporine

Study Locations (1)

Maine

  • Eye Center Northeast - Bangor

Trial Details

FieldValue
Phase Phase 3
Sirion Therapeutics

8 total trials

What the finished NCT00502073 record still lists

NCT00502073 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 1 intervention - of which cyclosporine is the first listed.

NCT00502073 reports a single indexed study location in Maine.

Frequently Asked Questions

What is clinical trial NCT00502073 about?

NCT00502073 is a clinical study titled "Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)". The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

What is the current status of trial NCT00502073?

This trial is currently completed. It is a Phase 3 study.

What conditions does trial NCT00502073 study?

This clinical trial studies the following conditions: Dry Eye Syndromes.

What interventions are being tested in trial NCT00502073?

The interventions under investigation include: cyclosporine (DRUG).

Who is sponsoring clinical trial NCT00502073?

This trial is sponsored by Sirion Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00502073 being conducted?

This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00502073, the US trial registry maintained by the National Library of Medicine. NCT00502073 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.